Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Fuchs

Showing results (51-60 of 257) with videos related to

Pageof 26
Sort By:
The Journal of Antimicrobial Chemotherapy|January 1, 1997
Effect of minor pH changes on the in-vitro activity of azithromycin and clarithromycinP C Fuchs, A L Barry, S D Brown
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Pneumococcal susceptibility to meropenemP C Fuchs, A L Barry, S D Brown
Diagnostic Microbiology and Infectious Disease|April 1, 1996
Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance. AST Surveillance GroupP C Fuchs, A L Barry, S D Brown
Antimicrobial Agents and Chemotherapy|January 1, 1993
Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acidA L Barry, P C Fuchs, M A Pfaller
The Journal of Antimicrobial Chemotherapy|December 16, 1998
Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centresA L Barry, P C Fuchs, S D Brown
Diagnostic Microbiology and Infectious Disease|January 1, 1989
Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaximeP C Fuchs, R N Jones, A L Barry
The Journal of Antimicrobial Chemotherapy|May 1, 1997
Provisional interpretive criteria for quinupristin/dalfopristin susceptibility testsA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|April 29, 1998
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin)A L Barry, P C Fuchs, S D Brown
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methodsP C Fuchs, A L Barry, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1997
In vitro activity of an orally administered streptogramin (RPR 106,972) compared to quinupristin/dalfopristin and erythromycinA L Barry, P C Fuchs, S D Brown
Pageof 26

Showing results (51-60 of 257) with videos related to

Sort By:
Pageof 26
The Journal of Antimicrobial Chemotherapy|January 1, 1997
Effect of minor pH changes on the in-vitro activity of azithromycin and clarithromycinP C Fuchs, A L Barry, S D Brown
The Journal of Antimicrobial Chemotherapy|May 1, 1996
Pneumococcal susceptibility to meropenemP C Fuchs, A L Barry, S D Brown
Diagnostic Microbiology and Infectious Disease|April 1, 1996
Survey of antimicrobial activity of four commonly used third generation cephalosporins tested against recent bacterial isolates from ten American medical centers, and assessment of disk diffusion test performance. AST Surveillance GroupP C Fuchs, A L Barry, S D Brown
Antimicrobial Agents and Chemotherapy|January 1, 1993
Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acidA L Barry, P C Fuchs, M A Pfaller
The Journal of Antimicrobial Chemotherapy|December 16, 1998
Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centresA L Barry, P C Fuchs, S D Brown
Diagnostic Microbiology and Infectious Disease|January 1, 1989
Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaximeP C Fuchs, R N Jones, A L Barry
The Journal of Antimicrobial Chemotherapy|May 1, 1997
Provisional interpretive criteria for quinupristin/dalfopristin susceptibility testsA L Barry, P C Fuchs, S D Brown
Antimicrobial Agents and Chemotherapy|April 29, 1998
Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin)A L Barry, P C Fuchs, S D Brown
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Fosfomycin tromethamine susceptibility of outpatient urine isolates of Escherichia coli and Enterococcus faecalis from ten North American medical centres by three methodsP C Fuchs, A L Barry, S D Brown
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1997
In vitro activity of an orally administered streptogramin (RPR 106,972) compared to quinupristin/dalfopristin and erythromycinA L Barry, P C Fuchs, S D Brown
Pageof 26